What? When? Why?

As per our report, the global infection control market size is expected to rise at a CAGR of 12.4% from 2021 to 2026 and be worth USD 78.4 billion by 2026.

The process of eradicating or preventing the spread of pollutants in healthcare environments is known as infection control. Its goal is to keep healthcare professionals and patients safe by reducing their exposure to viruses, bacteria, parasites, and fungus that can cause infections in the respiratory, ear, eye, skin, and urinary system. It entails a variety of procedures, including regular vaccines, sneezing and coughing treatment, and the use of protective equipment, such as gloves, masks, and surgical drapes and gowns. Viruses, bacteria, fungus, and parasites are the most common causes of infections. Stomach and intestine infections, lung and respiratory infections, eye and ear infections, hospital-acquired infections (HAIs), skin infections, and sexually transmitted infections are all examples of infections. In addition, cross-infection from the patient's surface and skin and equipment, and healthcare personnel can cause these diseases.

Impact of COVID-19 on the global infection control market:

With the COVID-19 severe outbreak, there is a global demand for modern healthcare facilities, services, and infrastructure to treat sick people that have never been seen before. Infection control products, such as personal protective equipment, are in high demand from most countries throughout the world due to a surge of COVID-19 patients. Healthcare personnel wears personal protective equipment (PPE) to keep themselves and their patients from being contaminated and infecting others. However, with the rapidly spreading COVID-19 epidemic, the existing face masks and gowns are insufficient, and the worldwide healthcare business is experiencing a crisis. In response to the COVID-19 pandemic, infection control product producers are increasing their ability to produce medical nonwoven and glove goods. Protective products and disposable medical supplies are projected to be in high demand as the number of COVID-19 cases rises and the need for healthcare personnel increases. Consequently, the COVID-19 infection boosted growth and opportunities for infection control product producers during the forecast period.

KEY DRIVING FACTORS:

The rise in the incidence of hospital-acquired infections, the increase in the number of surgical procedures requiring high-intensity infection prevention and control are majorly accelerating the growth rate of the global infection control market.

In addition, the rise in the number of government awareness programs aimed at ensuring high-level infection prevention, the increase in the geriatric population, and the increase in cases of chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders are expected to drive the market's growth. A urinary tract infection is the most prevalent type of hospital-acquired infection. Increased innovative technologies implemented in infection-control devices, awareness of personalized medicines, and cost-effective drugs to treat hospital-acquired infections are just a few factors driving the market's growth.

The demonstrated benefits of sterilized items and increased awareness of their effectiveness in healthcare settings are expected to stimulate demand for infection services. In addition, increased demand for sterilization and disinfection in hospitals and clinics, technological advancements in sterilization and disinfection equipment, increased outsourcing of sterilization services among hospitals, pharmaceutical, and medical device companies, and increased production of medical nonwovens and single-use products due to an increase in COVID-19 cases are expected to propel the infection control market forward in future.

RESTRAINING FACTORS:

The global infection control market is projected to be restrained by the adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed devices. The main hurdles were high nursing staff turnover, the time required to train new personnel, language proficiency challenges, and significant clinical workloads. Primary facilitators were a well-developed infection control team and an institutional climate that prioritized infection control.

Avail free sample market brochure of the report to evaluate report usefulness, get a copy @ https://www.marketdataforecast.com/market-reports/infection-control-market/request-sample

KEY MARKET INSIGHTS:

• Based on the product, the disinfectant segment is expected to have a significant share in the global infection control market during the forecast period. Except for bacterial spores from inanimate items, disinfection is defined as a technique that destroys many or all pathogenic microorganisms. Wet pasteurization or liquid chemicals are used to accomplish this. Several factors have influenced disinfection efficiency, each of which may limit the process' efficacy. Early cleaning of the object, the organic load on the item, the type and quantity of microbiological impurity, and the physical configuration of the object are some of the factors that have been proven to affect disinfection efficacy.
• Based on end-users, in 2020, hospitals and clinics segments are expected to hold the most significant share of the overall infection control market. The increased prevalence of hospital-acquired infections (HAIs) and the increasing number of surgical procedures are primarily responsible for this segment's substantial share. Apart from these factors, the dominance of this segment was bolstered by rising chronic diseases associated with an aging population, increasing awareness among people for quality care, rising hospitalization, and a focus on reducing the healthcare burden caused by HAIs.
• During the forecast period, the Asia Pacific region is expected to develop at the quickest CAGR. Accelerated economic growth in many countries, increased government focus on the healthcare sector, rising prevalence of chronic diseases, COVID-19 pandemic outbreak, government investment in healthcare facility expansion, and favorable regulatory reforms are the factors driving the Asia-Pacific market's growth. In addition, the market is expected to grow due to increased demand for medical nonwoven products, increased financing from the government and non-government sectors to raise awareness about infection prevention and control, and the presence of a large population base. Furthermore, leading manufacturers' increased attention to increasing their geographical presence in growing Asia-Pacific countries to gain high market share is likely to fuel the region's expansion of infection control.
• North America now leads the market and is projected to remain so for the near future. North America, particularly the United States and Canada, has made significant progress toward achieving the collective aim of eliminating HAIs. As a result, healthcare in this region is today safer than it was even ten years ago. It is vital to build on this accomplishment and continue to eliminate hospital-acquired infections, which has contributed to North America's most significant market share.
• 3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group are a few of the key participants in the global infection control market.

The report can be customized as per your requirements; talk to the team @ https://www.marketdataforecast.com/market-reports/infection-control-market/customization

MARKET SEGMENTATION:

By Products and Services:

• Cleaning and disinfection products
• Sterilization products and services
• Endoscope reprocessing products
• Protective equipment
• Others

By End-User:

• Hospitals and clinics
• Medical device companies
• Pharmaceutical companies
• Life sciences companies
• Food Industry
• Others

By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

BROWSE REGIONAL REPORTS:

• U.S. Infection Control Market
• Europe Infection Control Market
• APAC Infection Control Market
• Latin America Infection Control Market
• MEA Infection Control Market